Literature DB >> 1976461

Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects.

F Müller1, H Rollag, S S Frøland.   

Abstract

Oxidative burst responses of monocytes and monocyte-derived macrophages (MDM) were studied in 40 subjects with HIV infection of different clinical stages. Oxidative burst was assessed as reduction of nitroblue tetrazolium (NBT) with or without stimulants. Results were determined as oxidative burst responses per cell and as a stimulatory ratio between stimulated and unstimulated NBT reduction. Cells from 12 HIV-seronegative homosexual men and 38 blood donors served as control groups. In patients with asymptomatic HIV infection, monocyte oxidative burst responses were reduced compared with the blood donors. In MDM from the same patients, stimulatory ratios were reduced. In AIDS patients, stimulatory ratios of both monocytes and MDM were reduced compared with controls. In contrast to the progressive deterioration of CD4+ lymphocyte counts as well as other immune functions in HIV infection, monocyte oxidative burst responses are impaired already in the asymptomatic phase of the infection, almost to the same extent as in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976461      PMCID: PMC1535145          DOI: 10.1111/j.1365-2249.1990.tb05396.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.

Authors:  G Poli; B Bottazzi; R Acero; L Bersani; V Rossi; M Introna; A Lazzarin; M Galli; A Mantovani
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV).

Authors:  F Müller; S S Frøland; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

4.  Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome.

Authors:  R G Washburn; C U Tuazon; J E Bennett
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

5.  A rapid densitometric microassay for nitroblue tetrazolium reduction and application of the microassay to macrophages.

Authors:  E Pick; J Charon; D Mizel
Journal:  J Reticuloendothel Soc       Date:  1981-12

6.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon.

Authors:  G A Rook; J Steele; S Umar; H M Dockrell
Journal:  J Immunol Methods       Date:  1985-09-03       Impact factor: 2.303

8.  Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.

Authors:  H W Murray; R A Gellene; D M Libby; C D Rothermel; B Y Rubin
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

9.  Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.

Authors:  P D Smith; K Ohura; H Masur; H C Lane; A S Fauci; S M Wahl
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages.

Authors:  J C Unkeless; H N Eisen
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  7 in total

1.  Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Authors:  Mathieu Goupil; Emilie Bélanger Trudelle; Véronique Dugas; Catherine Racicot-Bergeron; Francine Aumont; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

2.  HIV-1 Nef regulates the release of superoxide anions from human macrophages.

Authors:  Eleonora Olivetta; Donatella Pietraforte; Ilaria Schiavoni; Maurizio Minetti; Maurizio Federico; Massimo Sanchez
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

3.  Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load.

Authors:  C Elbim; S Pillet; M H Prevost; A Preira; P M Girard; N Rogine; H Matusani; J Hakim; N Israel; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 4.  Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

Authors:  N Chirmule; S Pahwa
Journal:  Microbiol Rev       Date:  1996-06

5.  Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients.

Authors:  F G Delemarre; A Stevenhagen; F P Kroon; M Y van Eer; P L Meenhorst; R van Furth
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

6.  Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism.

Authors:  Ivan Vujkovic-Cvijin; Richard M Dunham; Shoko Iwai; Michael C Maher; Rebecca G Albright; Mara J Broadhurst; Ryan D Hernandez; Michael M Lederman; Yong Huang; Ma Somsouk; Steven G Deeks; Peter W Hunt; Susan V Lynch; Joseph M McCune
Journal:  Sci Transl Med       Date:  2013-07-10       Impact factor: 17.956

Review 7.  Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.

Authors:  A Roulston; R Lin; P Beauparlant; M A Wainberg; J Hiscott
Journal:  Microbiol Rev       Date:  1995-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.